Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-006050

Options or other derivatives

  • Director acquired 15,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Russell Lesley Director 2024-03-06 Grant or award · Stock Option (right to buy) +15,700 15,700 D: show line 1 in the form
Loading xslF345X05/form4.xml…